Skip to main content

Table 4 Univariate and Multivariable analysis of factors potentially predictive of disease specific survival

From: High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis

Characteristics

Total(N)

Univariate analysis

Multivariate analysis

Hazard ratio (95% CI)

P value

Hazard ratio (95% CI)

P value

Age

1062

    

 <  = 60

590

Reference

   

 > 60

472

1.445 (0.941–2.219)

0.093

1.280 (0.751–2.180)

0.364

T stage

1059

    

T1

274

Reference

   

T2&T3&T4

785

1.781 (1.033–3.071)

0.038

1.271 (0.525–3.080)

0.595

N stage

1044

    

N0

511

Reference

   

N1&N2&N3

533

3.797 (2.222–6.489)

 < 0.001

2.840 (1.451–5.559)

0.002

M stage

903

    

M0

884

Reference

   

M1

19

7.454 (3.988–13.931)

 < 0.001

6.663 (3.139–14.142)

 < 0.001

Pathologic stage

1041

    

Stage I

178

Reference

   

Stage II&Stage III&Stage IV

863

3.396 (1.478–7.803)

0.004

1.118 (0.300–4.165)

0.869

ER status

1013

    

Negative

232

Reference

   

Positive

781

0.559 (0.351–0.891)

0.015

0.435 (0.193–0.978)

0.044

PR status

1010

    

Negative

334

Reference

   

Positive

676

0.519 (0.334–0.807)

0.004

0.707 (0.321–1.555)

0.388

HER2 status

704

    

Negative

550

Reference

   

Positive

154

1.477 (0.740–2.948)

0.269

  

radiation_therapy

977

    

No

430

Reference

   

Yes

547

0.791 (0.483–1.295)

0.351

  

HSPB1

1062

    

Low

528

Reference

   

High

534

1.515 (1.239–1.837)

0.029

  
  1. TMN stage was according to the seventh edition of the Guidelines for the American Journal of Critical Care. ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor. Bold values indicate that p < 0.05